The Canadian cancer research conference #CCRC2025 is now a wrap and #CCTG had a number of poster presentations and an oral presentation on the Development of Patient Priorities in Cancer Research by Judy Needham! Find out more: buff.ly/PSMnJ4S

#CCTG and #CancerResearchInstitute announce the first patient enrolled in a new sub-study for the #IPROC ovarian cancer #immunotherapy platform trial - a new #immunotherapy combination and patient population, accelerating progress toward more effective ovarian cancer treatments. buff.ly/rQWkoeZ

November is #LungCancerAwareness Month and #CCTG is raising awareness about lung cancer, its risks, and current research. The BR38 trial is looking at targeted radiotherapy during #immunotherapy for metastatic non-small cell #lungcancer buff.ly/zDyZu8M

#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. www.ctg.queensu.ca/bulletin/cct...

A special Seminar with Dr Jean Desy where he discusses working on the North Shore of Quebec, in Cree country and among the Inuit of Nunavik for 47 years. Teaching literature and medicine at the Faculty of Medicine at Laval University for 23 years. buff.ly/CfRbmSE

Thanks to the #CCTG sites and #breastcancer patients who participated, making Canada one of the top 10 accruing countries globally. Showing that it is possible to have a temporary interruption of endocrine therapy to permit pregnancy. @cancersociety.bsky.social @ccsresearch.bsky.social

Results from the primary analysis of the ctDNA-negative cohort from the international DYNAMIC-III (CO29) colon cancer clinical trial were presented at the #ESMO25 Presidential Symposium and simultaneously published in #NatureMagazine. @agitg @petermaccc @ccsresearch @cancersociety buff.ly/YeYWTde

Dr Glenwood Goss presents the #CCTG #BR31 study final overall survival and minimal residual disease analyses today at #ESMO25. The trial tested whether there is a benefit to receiving adjuvant immunotherapy after tumour resection in early-stage non-small cell lung cancer.

Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...

The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > buff.ly/ybihH1Y

#BreastCancerAwarenessMonth the #CCTG MAC30 trial is testing the addition of chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning #PinkRibbon, #BCAM buff.ly/ABW5gHI

The Q3 2025 listing of #CCTG trials in development is now live. Find out what trials will be made available soon and which trials have been recently activated > buff.ly/MZzXJI1 buff.ly/MZzXJI1

The Canadian Cancer Trials Group #CCTG is currently seeking applications for a Patient Representative to support the #Gastrointestinal Disease Site Committee. Find out more > buff.ly/kgWqbn7

October is #LiverCancerAwarenessMonth and the #CCTG HE2 trial researchers want to know if the combination of three common drugs used to treat #livercancer can offer better results than the standard treatment. buff.ly/Laeecvk

Come join the #CCTG team - apply today for the position of Human Resources and Staffing Operations Leader, responsible for a range of Human Resources and Staffing activities in support of the administration and operation of the group. buff.ly/iSuoC3n

October is #BreastCancerAwarenessMonth and the #CCTG MAC27 trial is investigating if the combination of a new drug and a commonly used drug is better at preventing HER2-positive #breastcancer from returning #BreastCancerCanada, #BCAM, #PinkForBreastCancer buff.ly/X6OHJjN

National Day for Truth and Reconciliation: CCTG acknowledges the intergenerational impacts of residential schools & colonization. We are committed to reconciliation - designing and conducting trials that are equitable, culturally safe, & accessible for all First Nations, Inuit, & Métis peoples.

#CCTG trial spotlight for #LeukemiaAwarenessMonth & #ChildhoodCancerAwarenessMonth: The ALC6 study is testing if adding another drug to standard treatment improves outcomes for young adults with newly diagnosed B-cell acute lymphoblastic leukemia. #myeloMATCH Trial Info -> buff.ly/TZ0YRC0

#CCTG Trial Highlight for #BloodCancerAwarenessMonth: The MY13 study is evaluating whether stopping injections after 18 months can maintain disease control and improve quality of life in older adults with multiple #myeloma. #MultipleMyeloma #CancerResearch #CCTG Trial Info -> buff.ly/X6EoYBI

Recognizing #GynecologicCancerAwarenessMonth CCTG VU2 trial - a study is to evaluate if specific testing of vulva cancer tissue removed by surgery provides useful information to decide if additional surgery is needed. #GCAM #MoveTheMessage Trial Info -> buff.ly/qmXEtyl

#CCTG trial spotlight for #GynecologicCancerAwarenessMonth: EN10 is exploring if some people with low-risk endometrial cancer can safely receive less treatment after surgery, reducing side effects without affecting outcomes. #EndometrialCancer #SolvingCancerTogether Trial Info -> buff.ly/HNFFDOt

September is #ChildhoodCancerAwarenessMonth. #CCTG is committed to advancing research and clinical trials that develop better outcomes for children and their families. #CancerResearch #SolvingCancerTogether #ChildhoodCancer

Today is #WorldCancerResearchDay—a reminder that research saves lives. #CCTG is committed to developing and conducting cancer clinical trials that lead to better outcomes for cancer patients globally. #CancerResearch #SolvingCancerTogether #Research

September is #GynecologicCancerAwarenessMonth. #CCTG is dedicated to clinical research that improves treatment options and outcomes for people facing #gynecologic cancers. #GynecologicCancerAwareness #SolvingCancerTogether

A 17-year global study led by the Canadian Cancer Trials Group(CCTG) shows that just 2.5 hrs/week of moderate exercise can reduce colon cancer recurrence by 28% and death by 37%. Read more on this research 👉 bit.ly/45fIFes #UNBResearch #ProudlyUNB

Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the #radiotherapy delineation benchmark case procedure, published in the Green Journal. 👉 Read it before your patients: bit.ly/4fLoatJ

Strong showing from #GUonc #patientadvocates @swog.org: Darrell Nakagawa at #S2427 BRIGHT & Joël Pointon at #CCTG-PR.26 kickoff mtgs. Exciting to see new #bladdercancer & #prostatecancer trials open! THANK YOU to SWOG GU Cmte & @supportingswog.bsky.social for including & elevating patient voices!

During #BloodCancerAwarenessMonth, we’re spotlighting HD12, a phase III #CCTG clinical trial evaluating a new targeted therapy combination against the current standard for early-stage #Hodgkinlymphoma. #BloodCancerResearch #SolvingCancerTogether Trial page -> buff.ly/n304NuP

#CCTG Trial Highlight for #LeukemiaAwarenessMonth : ALC8 is testing four innovative treatment combinations for newly diagnosed high-risk acute #myeloid #leukemia to find better first-line options for patients. #myeloMATCH #SolvingCancerTogether Trial info -> buff.ly/NLWIgT7

The CCTG 2024 Annual Report is now live! Explore the achievements from the past year, highlighting the impact of our research and commitment to improving outcomes for people with cancer. buff.ly/4fcOXSh

This #OvarianCancerAwarenessMonth, #CCTG continues the research toward new and better treatment options for #ovariancancer patients. #SolvingCancerTogether #CancerResearch

Blood cancers affect thousands of Canadians every year and #CCTG recognizes #BloodCancerAwarenessMonth and the importance of research that leads to better therapies and improved outcomes. #BloodCancerAwareness #ClinicalTrials #SolvingCancerTogether

In recognition of #BreastCancerResearchDay, we spotlight the #CCTG MAC30 trial comparing chemotherapy plus hormonal therapy vs hormonal therapy alone in pre-menopausal early breast cancer. #BreastCancer #SolvingCancerTogether

The #CCTG MAC29 trial is investigating treatment with immunotherapy vs observation in people with triple-negative breast cancer after initial treatment with chemotherapy and immunotherapy. #BreastCancerResearchDay #SolvingCancerTogether

As little as 22 minutes of exercise a day could make a difference in colon cancer patients' survival, research concludes. Read about how UNB's research mission helped enable Dr. Anthony Reiman's participation in a landmark study, and what that research means for you: blogs.unb.ca/newsroom/202...

Today we acknowledge #BreastCancerResearchDay, as reminder of the ongoing work to improve care through research. At #CCTG, we're committed to advancing breast cancer clinical trials that make a difference. #ClinicalTrials #SolvingCancerTogether

The #CCTG HE2 trial has open and is testing whether a new three-drug combination can improve outcomes for people with #liver #cancer who haven't had prior treatment. #LiverCancer #HCC #CancerResearch #SolvingCancerTogether @cancersociety.bsky.social

The #CCTG SR.8 HARMONY trial has received nearly $1.5M in #CIHR funding. The Canadian-led phase III study that aims to find a new therapy for high-risk soft-tissue #sarcoma using #immunotherapy and new #radiation approaches. #SarcomaResearch #SolvingCancerTogether @cancersociety.bsky.social

#CCTG spotlights the BRC8 clinical trial recognizing #WorldLungCancerDay: Researchers are investigating if regular MRI surveillance can be as effective as MRI with preventive brain radiation for people with small cell #lungcancer. #SolvingCancerTogether Trial page -> buff.ly/mPsQZyN

Recognizing #WorldLungCancerDay, today we spotlight on the #CCTG BR38 clinical trial, testing whether adding targeted radiotherapy to ongoing #immunotherapy can improve outcomes for people with metastatic non-small cell #lungcancer. #SolvingCancerTogether Trial page -> buff.ly/SZBdNcF

Today, on #WorldLungCancerDay, we acknowledge the global impact of lung cancer and highlight the importance of ongoing clinical trials to improve cancer care for everyone. #CancerResearch #CCTG #SolvingCancerTogether

#CCTG is featuring the HN13 clinical trial comparing the effects on patients and their cancer of using targeted stereotactic body radiotherapy (SBRT) compared with current standard radiation therapy. #HeadandNeckCancerAwarenessDay #SolvingCancerTogether Trial info-> buff.ly/3KGrStm

#CCTG spotlights the HN11 clinical trial testing the effectiveness of radiotherapy guided by lymph node mapping using a special X-ray (SPECT-CT) compared to the current standard treatment where radiotherapy is given to both sides of the neck . #HeadandNeckCancerAwarenessDay buff.ly/JDb76gm

Today is #WorldHeadandNeckCancerDay and at #CCTG, we remain committed to advancing treatment options and improving outcomes for people affected by head and neck cancers. #HeadAndNeckCancer #SolvingCancerTogether #ClinicalTrials #CancerResearch

#CCTG Trials in Development quarterly update is now available. These are planned studies advancing cancer research across multiple disease sites. Keep an eye out for updates as new trials open for enrollment! #SolvingCancerTogether #CancerResearch #ClinicalTrials buff.ly/6VDElKO

#CCTG’s BR38 trial has opened in Canada. The study is investigating if targeted radiotherapy added to ongoing immunotherapy can enhance treatment outcomes for metastatic non-small cell lung cancer. #LungCancer #SolvingCancerTogether buff.ly/B77E4vA

#CCTG’s SKC1 trial has opened in Canada. This study is evaluating whether adding immunotherapy to surgery can improve outcomes for individuals with advanced skin cancer. #SkinCancer #SolvingCancerTogether buff.ly/51M10Dh

On #GlioblastomaAwarenessDay , #CCTG honors those affected by brain cancer and recognizes the ongoing need for research, innovation, and support in the fight against this aggressive form of #BrainCancer #SolvingCancerTogether

As we observe #BoneCancerAwarenessMonth, it is time to recognize the need for better treatments and support for those living with bone cancer through trials like SC29, exploring new ways to manage pain using targeted #RadiationTherapy. #CCTG Trial page - > buff.ly/DbQoPiH

July is #BoneCancerAwarenessMonth. At #CCTG, we’re committed to advancing clinical trials that help improve treatment options and outcomes for people living with rare bone cancers like sarcoma. #SarcomaAwarenessMonth #SolvingCancerTogether